This model is also consistent with reports demonstrating that RB loss facilitates translesion synthesis in the presence of crosslinking agents (Bosco et al, 2004) and that RB-null cancers are sensitive to loss of a number of DNA damage repair proteins (Aubry et al, 2020). Here, RB1 is linked to cancer.